Status: current, Defined. Date: 30-Apr 2021. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4554011000168115 | Ultomiris (ravulizumab 300 mg / 3 mL) injection, 3 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4554021000168110 | Ultomiris 300 mg/3 mL injection, 3 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Ultomiris 300 mg/3 mL injection, 3 mL vial | Is a | Ultomiris | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/3 mL injection, 3 mL vial | Is a | ravulizumab 300 mg/3 mL injection, vial | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/3 mL injection, 3 mL vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/3 mL injection, 3 mL vial | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Ultomiris 300 mg/3 mL injection, 3 mL vial | has unit of use | vial | true | Inferred relationship | Some | 1217541819 | |
| Ultomiris 300 mg/3 mL injection, 3 mL vial | has Australian BoSS | ravulizumab | true | Inferred relationship | Some | 185470804 | |
| Ultomiris 300 mg/3 mL injection, 3 mL vial | has intended active ingredient | ravulizumab | true | Inferred relationship | Some | 185470804 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Ultomiris 300 mg/3 mL injection, 3 mL vial | has TPUU | True | Ultomiris 300 mg/3 mL injection, 3 mL vial | Inferred relationship | Some | 1553075680 |
| Ultomiris 300 mg/3 mL injection, 3 mL vial | has TPUU | True | Ultomiris 300 mg/3 mL injection, 3 mL vial | Inferred relationship | Some | 867116359 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR